A monoclonal antibody (145-2C11) specific for the murine T3 complex was derived by immunizing Armenian hamsters with a murine cytolytic T-cell clone. The antibody is specific for a 25-kDa protein component (T3-e) of the antigen-specific T-cell receptor. It reacts with all mature T cells and can both activate and inhibit T-cell function. These results identify T3-E as a cell surface protein involved in the transduction of activation signals.
Activation of mature T cells is a process that requires both receptor occupancy by foreign antigen in the context of major histocompatibility complex (MHC) proteins and transduction of a transmembrane signal. The specific antigen recognition has been shown to be dependent on a disulfide-linked heterodimer containing two integral membrane glycoprotein chains, a (45-50 kDa) and / (40-44 kDa) (1) . The a and /3 chains are encoded by families of genes, giving rise to a polymorphic set of cell membrane receptors clonally expressed on T lymphocytes. Dembic et al. (2) and Saito et al. (34) have demonstrated that transfection and expression of the genes encoding the aB heterodimer results in the acquisition of MHC-restricted antigen recognition, establishing the direct relationship of antigen specificity to aB expression. The second step of T-cell activation (transmembrane signaling) is presently thought to be mediated by an invariant complex of proteins (T3) that by immunoprecipitation has been shown to be noncovalently associated with the af3 heterodimer in the T-cell receptor (TCR) complex (3, 4) . The human T3 complex consists of at least three polypeptides, two glycosylated proteins of 25 kDa and 20 kDa (T3-8 and T3-y, respectively) and an endoglycosidase F-insensitive protein of20 kDa (T3-E) (5) . The murine T3 structure has been identified as a similar complex of low molecular mass proteins, including T3-8, T3-e, T3-y, and a 16-kDa polypeptide present as a 32-kDa homodimer (T3-t) (6) (7) (8) . The role of the T3 proteins in transmembrane signaling is substantiated by the finding that several of the T3 components have a long intracellular polypeptide portion (9) (10) (11) that is phosphorylated upon af3 heterodimer occupancy (12) . In addition, monoclonal antibodies (mAbs) binding to the human T3-8 molecule can result in a rise in cytoplasmic free calcium (13) , metabolism of phosphatidylinositol phosphates (14) , T-cell proliferation (15) , lymphokine production (16) , and cytolysis (17, 18) . Recently, mAbs to T3 have allowed the identification of a subpopulation of human T cells that express T3 but not the a,8 heterodimer (19, 20) . In these cells, the T3 components are associated on the cell surface with polypeptides other than a and 83, including one that appears to be the product of the y gene (19) . Anti-T3 mAbs have been shown to activate this T-cell subset, indicating that T3 might also be involved in the signaling of activation signals initiated by the recently described TCRY receptor complex (20) .
Unlike the study of human systems, the study of murine T-cell activation and ontogeny has been hampered by the lack of monoclonal antibodies able to detect cell surface expression of murine T3-associated structures. In this paper we describe a mAb specific for the murine T3 complex. The antibody was generated by immunizing Armenian hamsters with a murine T-cell clone and was identified by means of a screening assay designed to detect mAbs directed at cell surface molecules involved in murine T-cell activation. This mAb reacts with a 25-kDa protein (identified as T3-E) that is noncovalently associated on the cell surface with the antigenspecific af3 heterodimer and has functional properties similar to anti-human T3-8 antibodies.
MATERIALS AND METHODS
Animals and Cell Lines. Adult Armenian hamsters (Cricetulus migratorius) were purchased from Cambridge Diagnostic (Cambridge, MA). All strains of mice used in this study were either obtained from The Jackson Laboratory or were bred in our own colony (National Institutes of Health, Bethesda, MD). Tumor cell lines used in this study included K562, a human erythroleukemia cell line, and 2B4, a cytochrome c-specific T-cell hybrid (21) . Cell lines were cultured in RPMI-1640 medium with 10% fetal bovine serum as described (21) .
Monoclonal Antibodies and Antisera. The anti-Ly-6C (144-4B11) and anti-Thy-1 (145-7B10) mAbs generated in our laboratory (J.A.B. and M.F.) are of Armenian hamster origin (data not shown). Other mAbs used included 83-12-5 (antiLyt-2.2, generated in our laboratory), (25) , specific for the murine T3-8 chain, was generated by immunizing a rabbit with a C-terminal peptide synthesized according to the amino acid sequence deduced from the cDNA sequence (10) .
Immunization and Fusion Protocols. Armenian hamsters were preferred over Syrian hamsters as recipients for immunizations because of the higher fusion efficiencies obtained with the murine myeloma SP2/0 (ref. 26 given a booster injection 2 weeks later with the same dose of antigen in incomplete Freund's adjuvant, and injected every 2-3 weeks intraperitoneally with cloned cells in 0.9% NaCi, for a total of six injections. After resting for 2-3 months, selected animals were given an intravenous booster injection (2 x 107 cells) and killed 3 days later. Fusion 145 was performed as follows: the spleen was aseptically removed and a single-cell suspension was prepared; 2 x 108 spleen cells were mixed with 2.5 x 107 cells of the murine myeloma cell line SP2/0, fused according to published protocols (28) , and distributed in 960 individual cultures. Growth of hybridoma cells was observed in 100% of the wells, suggesting that more than one clone was present in each culture. Supernatant of each culture was tested for its ability to induce the H-2Kb-specific CTL clone BM10-37 to lyse the H-2Kb_ negative target cell K562, according to a protocol recently developed in our laboratory. We have recently shown (29) that antibodies to the TCR complex, including antibodies to murine TCR or anti-human T3 mAbs can redirect lysis of effector CTL to non-antigen-bearing, Fc receptor-positive targets. Anti-TCR complex antibodies probably trigger the lytic function by binding to TCR-complex structures on the effector population and provide cell-cell contact with the target cell through Fc receptor binding (29) . Following this protocol, we cultured BM10-37 cells (104) The percent specific lysis was determined as previously published (27) . Hybridoma culture supernatants were scored as positive when >10% specific lysis of the K562 target was observed. 4- 
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2-~A Flow Cytometric Analysis. Flow cytometry was performed as described (30) , using a modified Becton Dickinson FACS II. Hamster antibodies were detected using a fluorescein isothiocyanate-conjugated anti-hamster immunoglobulin reagent (Cooper Biomedical, Malvern, PA). Cell separations were performed as follows. Splenic T cells (>95% Thy-i.2+) were prepared by double passage over a rabbit anti-mouse immunoglobulin antibody-coated plate as described (31) . Non-T cells (>95% surface immunoglobulin-positive) were obtained after treating spleen cells with an anti-Thy-1.2 mAb (HO-13-4, ref. 22 ) and rabbit complement.
Biochemical Analysis. Cell surface radioiodination of the 2B4 T-cell hybrid by the lactoperoxidase-catalyzed reaction was done as described (7). Immunoprecipitation Was performed with complexes prepared by adsorbing the relevant antibody to protein A-coupled Sepharose beads (Pharmacia, Uppsala, Sweden). Solubilized precipitates were electrophoresed in 13% polyacrylamide gels as described (7) . Mild dissociation ofthe complexes was achieved by incubating the washed, immunoprecipitated complexes with 50 mM Trist HC1, pH 7.6/300 mM NaCl/0.2% NaDodSO4/0.1% Triton X-100/0.2% sodium deoxycholate on ice for 30 min, and the dissociated complexes were analyzed by electrophoresis. For two-dimensional electrophoresis, immunoprecipitated complexes were eluted in the absence of reducing agents and Proc. Natl. Acad. Sci. USA 84 (1987) electrophoresed in a 13% polyacrylamide tube gel (left to right in Fig. 2 B and C) . After electrophoresis, the gel was equilibrated with 0.5% dithiothreitol in 0.1% NaDodSO4 and the reduced proteins were electrophoresed in a slab gel as described (7) .
In Vitro Assay Cultures. Primary mixed lymphocyte reactions and CTL effector-function analyses were as described (27) . The mitogenic properties of the mAbs were assessed by proliferation assays. T cells (105) 
RESULTS AND DISCUSSION
The purpose of this study was to generate mAbs specific for cell surface structures involved in murine T-cell activation. Armenian hamsters rather than rats were injected with a murine alloreactive cytolytic clone (BM10-37) to maximize the phylogenetic difference between responder and immunogen while retaining the ability to generate monoclonal antibodies (26) . Splenic cells from hyperimmunized animals were fused to the SP2/0 myeloma line, and supernatants of cultures containing hybridoma cell lines were screened for their ability to activate the lytic function of murine CTL clones in the absence of specific antigen recognition. This procedure has been shown (29) to preferentially detect antibodies directed at molecules mediating T-cell activation while avoiding the detection of those mAbs that, by binding to Lyt-2 or lymphocyte function-associated antigen 1 (LFA-1) molecules, inhibit antigen-specific cytolysis. Induction of lytic activity was preferred over the induction of proliferation as a screening procedure for anti-T3 mAbs because anti-Thy-1 mAbs, which account for the majority of xenogeneic mAbs produced, induce T-cell proliferation (32) but not CTL function (O.L. and J.A.B., unpublished observation). One antibody, 145-2C11, was found to effectively redirect lysis by a murine H-2Kb-specific CTL clone to the H-2Kb-negative, Fc receptor-positive human target cell line K562. The hybrid cell line producing 145-2C11 was therefore subcloned by limiting dilution and used for further studies.
The expression of the 145-2C11-defined epitope on lymphoid tissues was studied by flow cytometry. The 145-2C11 antibody reacted with a subpopulation of lymphoid cells from all mouse strains examined but did not react with peripheral lymphocytes from rats, rabbits, miniature swine, or hamsters. Peripheral T cells but not B cells (Fig. 1) or bone marrow cells (data not shown) expressed this determinant. Although the expression of the 145-2C11 epitope on peripheral T cells was uniformly high, the staining of thymocytes revealed distinct subpopulations of cells differing in the level of expression of the 145-2C11 marker (Fig. 1) . Preliminary studies identified the subpopulation of thymic cells expressing high levels of the 145-2C11 epitope as the phenotypically mature (L3T4+,Lyt-2-and L3T4-,Lyt2+) thymocytes, whereas the remaining T cells express low but significant levels of the 145-2C11 antigen (J.A.B., B. J. Fowlkes, and S. Sharrow, unpublished results). Finally, all monoclonal T-cell lines tested, including many T-cell tumors and antigenspecific T-cell hybridomas, helper T cells, and CTL clones, expressed the 145-2C11 determinant (data not shown).
Immunoprecipitation studies were performed to determine whether 145-2C11 would react with a component of the TCR-T3 complex (Fig. 2 ). An antigen-specific T-cell hybrid, 2B4 (21), was surface-labeled with 1251I by the lactoperoxidase method and then solubilized with detergent. Aliquots of the radiolabeled material were immunoprecipitated and analyzed by polyacrylamide gel electrophoresis under reducing conditions. The clone-specific anti-TCR antibody (A2B4-2, ref.
21) immunoprecipitated the a and P chains of the TCR (42-45 kDa), as well as five additional proteins of lower molecular mass comprising the murine T3 complex (Fig. 2A, lane a) . The dense 25-to 26-kDa band contained two polypeptides, a 26-kDa endoglycosidase-sensitive glycoprotein (T3-8) and a 25-kDa endoglycosidase-resistant protein, presently thought to represent the homologue of the human T3-e chain. In addition, two bands at approximately 21 kDa and 16 kDa (gp2l and T3-t) were also apparent. A 36-kDa TCR protein was also observed, which may represent cleavage products of the heterodimer. As seen in Fig. 2A (lanes b and c) , both a rabbit serum specific for the T3-8 chain (25) and the 145-2C11 mAb coprecipitated the a and , chains of the TCR hetero- were obtained by using a wide range of antibody concentrations (from 50 Al to 1 1.l of culture supernatant, data not shown). E/T, effector/target ratio. *Designations of mAbs are given in Table 1. dimer and the proteins ofthe T3 complex. Control antibodies, including culture supernatant from hybridoma lines secreting irrelevant hamster antibodies, failed to immunoprecipitate any material from the labeled cells (data not shown). In order to determine which polypeptide chain was specifically recognized by the 145-2C11 mAb, the immunoprecipitated complexes were dissociated by treatment with ionic detergents before electrophoresis ( Fig. 2A, lanes d-f) . Lane d shows that after detergent treatment, the two bands corresponding to the a and , subunits of the TCR are specifically retained in the A2B4-2 immunoprecipitate, indicating that this antibody binds to the TCR heterodimer. In contrast, both the R9 serum and the 145-2C11 mAb were specific for components of the murine T3 complex. A comparison of lanes e and f in Fig. 2A indicates that the R9 anti-T3-8 antiserum recognized the larger 26-kDa protein, whereas the 145-2C11 mAb recognized the smaller protein (T3-e) in the dense 25-to 26-kDa band. The specificity of mAb 145-2C11 was confirmed by two-dimensional electrophoresis, which allowed a better resolution of the dense 25-to 26-kDa band observed in one-dimensional gels. Two-dimensional gel analysis of the 145-2C11 immunoprecipitate (Fig. 2B ) resulted in a distinct migration pattern of proteins previously observed by ourselves and others using either anti-TCR antibodies (6) or the R9 antiserum (25) . The antigen-specific TCR consisted of a disulfide-linked heterodimer (a and ,B) migrating below the diagonal. The disulfide-linked homodimer of the 16-kDa proteins (T3-4) is resolved below the diagonal; both the 26-kDa (T3-C) and the 21-kDa (gp2l) subunits migrate along the diagonal; the fourth chain, the 25-kDa protein (T3-e) runs above the diagonal with an apparent molecular mass of 22 kDa when not reduced and 25 kDa when reduced, suggesting the presence of intrachain disulfide bond(s). Dissociation by detergent treatment demonstrated that the mAb 145-2C11 reacts with T3-e (Fig. 2C) .
The functional properties of the anti-T3-e mAb were also studied. Murine CTLs specific for the H-2Kb and H-2Db molecules were generated during a primary allogeneic mixed lymphocyte reaction by culturing, respectively, B6.CH-2bmll Table 1 , mAb 145-2C11 inhibited the lysis of the target cells by the antigen-specific CTL effectors. Hamster mAbs specific for other murine T-cell surface markers expressed by CTLs, such as Ly-6C (144-4B11) or Thy-1 (145-7E12), did not inhibit CTL activity.
The ability of the 145-2C11 mAb to activate murine T cells is shown in Tables 2 and 3 . The ability of mAbs to redirect lysis of murine CTLs to irrelevant target cells was assessed. As expected, none of the alloreactive murine CTLs signifi- tSpleen cells were incubated with antibodies to the Lyt-2 or L3T4 molecules followed by rabbit complement (C'). In both cases, antibody treatment resulted in the elimination of >95% of the corresponding cell population, as judged by flow cytometry (data not shown). tPhorbol 12-myristate 13-acetate (10 ng/ml). §Recombinant interleukin 2 (50 units/ml).
$mAb 145-8B10.
Immunology: Leo et al.
Proc. Natl. Acad. Sci. USA 84 (1987) cantly lysed the human target cell K562 in the absence of mAb (Table 2) . However, addition of culture supernatant from the hybridoma secreting the anti-T3-e mAb resulted in the lysis of target cells. The lysis was dependent on the presence of effector CTLs, as incubation of the K562 cells with the mAb alone did not result in target-cell lysis (data not shown). None of several other antibodies, including anti-Lyt-2.2 and anti-LFA-1 mAbs, that inhibited antigen-specific lytic activity (see Table 1 ) were able to promote lysis of the K562 targets by the CTL effectors. This ability to redirect lysis of the BM10-37 CTL clone to the K562 target had in fact been used as the screening procedure for identifying the 145-2C11 mAb (data not shown).
The ability of mAb 145-2C11 to induce T-cell proliferation was also studied ( 
